Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Acetylcholinesterase (AChE) is a serine hydrolase enzyme that catalyzes the rapid hydrolysis of the neurotransmitter acetylcholine (ACh) into choline and acetic acid. It is primarily found at neuromuscular junctions and cholinergic brain synapses and plays a crucial role in terminating synaptic transmission by removing ACh from the synaptic cleft. Inhibition of AChE leads to the accumulation of acetylcholine, causing prolonged stimulation, and is the basis for toxicity seen with organophosphorus compounds. Therapeutic inhibitors are used in the treatment of Alzheimer’s disease and certain neuromuscular disorders.
Hydrolyzes acetylcholine into choline and acetic acid, terminating synaptic transmission.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Acetylcholinesterase (AChE).